0001593968-19-001775.txt : 20190821 0001593968-19-001775.hdr.sgml : 20190821 20190821182647 ACCESSION NUMBER: 0001593968-19-001775 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190819 FILED AS OF DATE: 20190821 DATE AS OF CHANGE: 20190821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moss Ronald B. CENTRAL INDEX KEY: 0001700786 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 191043958 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2019-08-19 0000887247 Adamis Pharmaceuticals Corp ADMP 0001700786 Moss Ronald B. C/O ADAMIS PHARMACEUTICALS CORPORATION 11682 EL CAMINO REAL, STE 300 SAN DIEGO CA 92130 false true false false Chief Medical Officer Common Stock 2019-08-19 4 S false 8383 1.0608 D 267872 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted in March 2019. The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.06 to $1.07, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/Robert O. Hopkins, Power of Attorney for Ronald B. Moss 2019-08-21